STMicroelectronics shares down as Morgan Stanley downgrades to "underweight"

Source Investing

Investing.com -- Shares of STMicroelectronics (EPA:STMPA) traded lower on Monday after Morgan Stanley (NYSE:MS) downgraded the stock to "underweight" from "equal-weight," citing mounting challenges within the automotive sector and overall sales declines anticipated in fiscal year 2025. 

The brokerage pointed to overestimated market expectations, especially in automotive, and believes that STMicroelectronics may struggle to meet optimistic projections. 

This stems partly from an inventory buildup in automotive components, which STMicroelectronics itself hinted at in its recent guidance, as well as competitive dynamics in pricing for automotive semiconductors.

Morgan Stanley analysts expressed concerns about weak utilization rates, which continue to strain margins across STMicroelectronics' automotive segments. 

They expect this under-utilization could affect margins well into 2025, compounding the pressure from higher depreciation costs tied to prior capital expenditures in semiconductor fabrication. 

The analysts further flag that recent channel checks have shown softened demand within the auto sector, especially amid a shift away from electric vehicles in Europe and the U.S., which may result in a more sluggish recovery trajectory than expected.

Another factor driving Morgan Stanley’s price target cut to €20 from €35 per share is the forecasted flat performance in other key business segments beyond automotive, such as industrial and personal electronics. 

The analysts warn of underwhelming sales recovery in these areas, suggesting that overall revenue for STMicroelectronics may decline by about 24% in 2024 and a further 4% in 2025. 

The semiconductor company also faces potential pricing pressures in China, where it is experiencing intense competition from local players, making margin recovery increasingly challenging.

This downgrade reflects a broader concern about the current semiconductor cycle, with Morgan Stanley analysts noting that STMicroelectronics is particularly vulnerable in comparison to peers like Infineon (OTC:IFNNY), given its greater exposure to China’s semiconductor market and automotive dependencies. 

The analysts suggest that a more cautious investor outlook may be prudent given the anticipated dip in automotive revenues and a tough road ahead for margin recovery​.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Analysts Predict These 5 Meme Coins to 10x by 2025The meme coin cumulative market cap waned by 11.79% this month. But those who’ve been riding the crypto rollercoaster for years know to buy the dip.
Author  Bitcoinist
10 hours ago
The meme coin cumulative market cap waned by 11.79% this month. But those who’ve been riding the crypto rollercoaster for years know to buy the dip.
placeholder
India’s economy is tumbling, and it might take whole world down with itIndia’s economy is spiraling. The rupee is sinking like a stone, dragging with it a mix of trade deficits, shrinking capital inflows, and uncertainty. The country’s economy has quickly become so important that if it plummets, the global economy will be at stake.
Author  Cryptopolitan
10 hours ago
India’s economy is spiraling. The rupee is sinking like a stone, dragging with it a mix of trade deficits, shrinking capital inflows, and uncertainty. The country’s economy has quickly become so important that if it plummets, the global economy will be at stake.
placeholder
Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NYSE: NVO) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage clinical trial that it framed as a success.
Author  The Motley Fool
10 hours ago
Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NYSE: NVO) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage clinical trial that it framed as a success.
placeholder
Shiba Inu Has Plummeted 41% From Its 52-Week High. Is It Time to Buy?Volatility has always been a feature of the cryptocurrency markets. The collective value of all coins and tokens in existence recently hit an all-time high of nearly $3.9 trillion, but the market is in correction territory again, with a 12% drop as of this writing.
Author  The Motley Fool
13 hours ago
Volatility has always been a feature of the cryptocurrency markets. The collective value of all coins and tokens in existence recently hit an all-time high of nearly $3.9 trillion, but the market is in correction territory again, with a 12% drop as of this writing.
placeholder
Crucial Bitcoin Metric Back To Healthy Bull Levels, Analyst RevealsAn analyst has explained how an important Bitcoin indicator is back to levels that may be considered healthy for a bull-market uptrend.
Author  Bitcoinist
13 hours ago
An analyst has explained how an important Bitcoin indicator is back to levels that may be considered healthy for a bull-market uptrend.
goTop
quote